Rheumatology International

, Volume 12, Issue 4, pp 147–151 | Cite as

Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis

  • J. G. Saal
  • M. Steidle
  • H. Einsele
  • C. A. Müller
  • P. Fritz
  • J. Zacher
Originals

Summary

Recent clinical observations support the hypothesis that persistent parvovirus B19 is a triggering factor of rheumatoid arthritis (RA) in certain genetically predisposed individuals. If this hypothesis is correct, a number of RA patients may exhibit parvovirus B19 DNA in their synovial membranes. We tested the synovial tissue and peripheral blood leukocytes of 20 patients with RA, 24 patients with other arthritides or osteoarthritis (non-RA), and 34 healthy blood donors for the presence of parvovirus B19 DNA using specific DNA amplification by polymerase chain reaction (PCR). Using this technique, parvovirus B19 DNA was demonstrated in the synovial biopsies of 75% of patients with RA but in those of only 16.7% of patients with non-RA. In autologous peripheral blood mononuclear cells the percentage of PCR-positive patients was about 15% in both RA and non-RA groups and did not differ from that in healthy controls. When the PCR data were correlated with the presence of anti-parvovirus B19 IgG antibodies in serum and synovia all patients with parvovirus B19 DNA in peripheral blood alone or in both peripheral blood and synovial membrane were seropositive. In contrast, about 40% of patients with parvovirus B19 DNA restricted to the synovial membrane were seronegative. These data indicate a highly disease-related persistence of parvovirus B19 in the rheumatoid synovium.

Key words

Rheumatoid arthritis B19 parvovirus Polymerase chain reaction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pattison JR (1990) Parvoviruses. In: Fields N, Knipe DM (eds) Virology. Raven, New YorkGoogle Scholar
  2. 2.
    Kurtzman GJ, Cohen BJ, Field HM et al (1989) Immune respone to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 84:1114–1123Google Scholar
  3. 3.
    White DG, Woolf AD, Mortimer PP et al (1985) Human parvovirus arthropathy. Lancet I:419–421Google Scholar
  4. 4.
    Reid DM, Reid TMS, Brown T et al (1985) Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet I:422–425Google Scholar
  5. 5.
    Cohen BJ, Buckley MM, Clewley JP et al (1986) Human parvovirus infection in an early rheumatoid and inflammatory arthritis. Ann Rheum Dis 45:832–838Google Scholar
  6. 6.
    Naides SJ, Scharosch CC, Foto T et al (1990) Rheumatologic manifestations of human parvovirus B19 infection in adults. Arthritis Rheum 33:1297–1309Google Scholar
  7. 7.
    Arnett FC, Edworth SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324Google Scholar
  8. 8.
    Frickhofen N, Young NS (1989) Persistent parvovirus B19 infections in humans. Microb Pathog 7:319–327Google Scholar
  9. 9.
    Koch WC, Adler SP (1990) Detection of human parvovirus B19 DNA by using the polymerase chain reaction. J. Clin Microbiol 28:65–69Google Scholar
  10. 10.
    Sevall JS (1990) Detection of parvovirus B19 by dot blot and polymerase chain reaction. Mol Cell Probes 4:237–246Google Scholar
  11. 11.
    Hassam S, Briner J, Tratschin JD et al (1990) In situ hybridization for the detection of human parvovirus B19 nucleic acid sequence in paraffin embedded specimens. virchows Arch [B] 59:257–261Google Scholar
  12. 12.
    Einsele H, Vallbracht A, Kandolf R et al (1989) Hybridization techniques provide improved sensitivity for HCMV detection and allow quantitation of the virus in clinical specimens. J Virol Methods 26:91–93Google Scholar
  13. 13.
    Permeen A, Sam CK, Pathmanthan R et al (1990) Detection of Epstein-Barr virus DNA in nasopharyngeal carcinoma using a non-radioactive digoxigenin-labelled probe. J Virol Methods 27:261Google Scholar
  14. 14.
    Einsele H, Steidle M, Vallbracht A et al (1991) Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood 77:1104–1110Google Scholar
  15. 15.
    Schwarz TF, Roggendorf M, Suschke H et al (1987) Human parvovirus B19 infection and juvenile chronic polyarthritis. Infection 15:264–265Google Scholar
  16. 16.
    Klouda PT, Corbin SA, Bradley BA et al (1986) HLA and acute arthritis following human parvovirus infection. Tissue Antigens 28: 318–319Google Scholar
  17. 17.
    Woolf AD, Campion GV, Klouda P et al (1986) HLA and the clinical manifestation of human parvovirus infection. Br J Rheumatol 25 [Suppl 1]:35Google Scholar
  18. 18.
    Dijkmans BAC, Breedveld FC, Vries RRP de (1986) HLA antigens in human parvovirus arthropathy. J Rheumatol 13:1192–1193Google Scholar
  19. 19.
    Simpson RW, McGinty L, Simon L et al (1984) Association of parvoviruses with rheumatoid arthritis of humans. Science 223:1425–1428Google Scholar
  20. 20.
    Naides SJ, Foto F, Scharosch LL et al (1991) Detection of parvovirus B19-specific DNA sequences in bone marrow aspirates from chronic B19 arthropathy patients. Cell Biochem 45 [suppl 15E]:157Google Scholar
  21. 21.
    Dijkmans BAC, Elsacker-Niele AMW van, Salimans MMM et al (1988) Human parvovirus B19 DNA in synovial fluid. Arthritis Rheum 31:279–281Google Scholar
  22. 22.
    Salimans MMM, Holsappel S, Rijke FM van et al (1989) Rapid detection of human parvovirus B19 DNA by dot blot hybridization and the polymerase chain reaction. J Virol Methods 23:19–28Google Scholar
  23. 23.
    Clewley JP (1989) Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol 27:2647–2651Google Scholar
  24. 24.
    Srivastava A, Bruno E, Briddell R et al (1990) Parvovirus B19 induced perturbation of human megakaryo-cytopoiesis in vitro. Blood 76:1997–2004Google Scholar
  25. 25.
    Lefrere JJ, Meyer O, Menkes CJ et al (1985) Human parvovirus and rheumatoid arthritis. Lancet I:982Google Scholar
  26. 26.
    Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662Google Scholar
  27. 27.
    Fritz P, Laschner W, Saal JG et al (1989) Histological classification of synovitis. Zentralbl Allg Pathol 135:729–741Google Scholar
  28. 28.
    Shade RO, Blundell MC, Cotmore SA et al (1986) Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 58:921–936Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • J. G. Saal
    • 1
  • M. Steidle
    • 1
  • H. Einsele
    • 1
  • C. A. Müller
    • 1
  • P. Fritz
    • 2
  • J. Zacher
    • 3
  1. 1.Department of Internal MedicineUniversity of TübingenTübingenFederal Republic of Germany
  2. 2.Department of PathologyRBK HospitalStuttgartFederal Republic of Germany
  3. 3.Department of OrthopedicsUniversity of TübingenTübingenFederal Republic of Germany

Personalised recommendations